The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

HybridDesign: Hybrid Design for Phase I Dose-Finding Studies

The Hybrid design is a combination of model-assisted design (e.g., the modified Toxicity Probability Interval design) with dose-toxicity model-based design for phase I dose-finding studies. The hybrid design controls the overdosing toxicity well and leads to a recommended dose closer to the true maximum tolerated dose (MTD) due to its ability to calibrate for an intermediate dose. More details can be found in Liao et al. 2022 <doi:10.1002/ijc.34203>.

Version: 1.0
Depends: R (≥ 3.6)
Imports: testit, ResourceSelection
Published: 2022-12-15
Author: Heng Zhou [aut, cre], Feng Zhou [aut], Jason Liao [aut]
Maintainer: Heng Zhou <heng.zhou at merck.com>
License: GPL-3
NeedsCompilation: no
CRAN checks: HybridDesign results

Documentation:

Reference manual: HybridDesign.pdf

Downloads:

Package source: HybridDesign_1.0.tar.gz
Windows binaries: r-devel: HybridDesign_1.0.zip, r-release: HybridDesign_1.0.zip, r-oldrel: HybridDesign_1.0.zip
macOS binaries: r-release (arm64): HybridDesign_1.0.tgz, r-oldrel (arm64): HybridDesign_1.0.tgz, r-release (x86_64): HybridDesign_1.0.tgz, r-oldrel (x86_64): HybridDesign_1.0.tgz

Linking:

Please use the canonical form https://CRAN.R-project.org/package=HybridDesign to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.